Ropinirole, a dopamine D2 receptor (DRD2) agonist, protects motor neurons harboring ALS‐linked TARDBP mutations via both DRD2‐dependent and DRD2‐independent mechanisms. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.